Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.jpeds.2015.02.043 | Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia |
| https://doi.org/10.5665/sleep.5168 | On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers |
| https://doi.org/10.1038/s41591-021-01479-3 | Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial |
| https://doi.org/10.1186/s12916-024-03322-1 | Low awareness of the transitivity assumption in complex networks of interventions: a systematic survey from 721 network meta-analyses |
| https://doi.org/10.2807/1560-7917.es.2024.29.45.2400108 | Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023 |
| https://doi.org/10.1016/j.amjcard.2013.08.031 | Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia |
| https://doi.org/10.1007/s00467-012-2372-9 | Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome |
| https://doi.org/10.1002/jrsm.1478 | Quantifying the robustness of primary analysis results: A case study on missing outcome data in pairwise and network meta‐analysis |
| https://doi.org/10.3109/13625187.2011.625882 | Does structured counselling influence combined hormonal contraceptive choice? |
| https://doi.org/10.1002/jbmr.3994 | Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension |
| https://doi.org/10.1002/jbmr.4284 | Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial |
| https://doi.org/10.1080/20016689.2021.1964791 | Accelerating patient access to oncology medicines with multiple indications in Europe |
| https://doi.org/10.1111/bcp.12547 | Characterizing the PK / PD relationship for inhibition of capsaicin‐induced dermal vasodilatation by MK ‐3207, an oral calcitonin gene related peptide receptor antagonist |
| https://doi.org/10.1017/s0266462321000131 | Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements |
| https://doi.org/10.1016/j.lungcan.2021.03.020 | Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison |
| https://doi.org/10.3390/cancers12123648 | A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC |
| https://doi.org/10.1016/j.rmed.2022.107065 | Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH) |
| https://doi.org/10.1177/0962280220983544 | Continuous(ly) missing outcome data in network meta-analysis: A one-stage pattern-mixture model approach |
| https://doi.org/10.1007/s12325-025-03144-4 | Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison |
| https://doi.org/10.1016/s0090-4295(01)01155-4 | Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials |
| https://doi.org/10.1111/j.1365-2125.2010.03869.x | The potent calcitonin gene‐related peptide receptor antagonist, telcagepant, does not affect nitroglycerin‐induced vasodilation in healthy men |
| Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. | |
| https://doi.org/10.1177/1479164112465212 | A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease |
| https://doi.org/10.1111/ijcp.12315 | Prevalence of persistent lipid abnormalities in statin‐treated patients: Belgian results of the Dyslipidaemia International Study ( DYSIS ) |
| https://doi.org/10.1111/1756-185x.13526 | Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort |
| https://doi.org/10.1002/sim.8207 | Participants' outcomes gone missing within a network of interventions: Bayesian modeling strategies |
| https://doi.org/10.2147/copd.s454905 | Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease |
| https://doi.org/10.1186/s12874-020-01205-6 | Pattern-mixture model in network meta-analysis of binary missing outcome data: one-stage or two-stage approach? |
| https://doi.org/10.1111/dom.12059 | The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid‐lowering treatment strategies in diabetic subjects with and without metabolic syndrome |
| https://doi.org/10.1007/s43441-024-00681-y | A Global Industry Survey on Post-Approval Change Management and Use of Reliance |
| https://doi.org/10.1093/haschl/qxae060 | Quantifying public and private investment in European biopharmaceutical research and development |
| https://doi.org/10.1111/cts.70331 | Safety and Pharmacokinetics of MK ‐8527 in Adults Without HIV |
| https://doi.org/10.1093/rheumatology/kew230 | Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics |
| https://doi.org/10.1016/j.ejheart.2008.07.004 | Design of the Heart Failure Endpoint Evaluation of AII-Antagonist Losartan (HEAAL) Study in Patients Intolerant to ACE-Inhibitor |
| https://doi.org/10.1177/2042098615579314 | A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone |
| Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study. | |
| https://doi.org/10.1186/1476-511x-12-103 | Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects |
| https://doi.org/10.2217/imt-2021-0273 | Indirect Comparison of Pembrolizumab Monotherapy Versus Nivolumab + Ipilimumab in First-Line Metastatic Lung Cancer |
| https://doi.org/10.1007/s10637-024-01462-y | A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants |
| https://doi.org/10.3390/jmahp14010003 | European Joint Clinical Assessment PICO Scoping Process: Analysis of Current Approaches and Recommendations |
| https://doi.org/10.1093/cid/ciag135 | Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies |
| https://doi.org/10.1016/0140-6736(92)92092-t | Simvastatin use in children |
| https://doi.org/10.1002/cpt.1121 | Medicines Adaptive Pathways to Patients: Why, When, and How to Engage? |
| https://doi.org/10.1007/s43441-023-00601-6 | Pediatric Market Access: A Qualitative Study |
| https://doi.org/10.1186/s12916-021-02195-y | How robust are findings of pairwise and network meta-analysis in the presence of missing participant outcome data? |
| https://doi.org/10.1016/j.jgar.2022.02.006 | Discrete choice experiment to investigate preferences for incentives to promote antimicrobial research and development |
| https://doi.org/10.1177/26320843231190026 | Dealing with censoring in a network meta-analysis of time-to-event data |
| https://doi.org/10.1371/journal.pgph.0005636 | Modeling the clinical and economic impact of universal varicella vaccination in Belgium with dynamic population |
| https://doi.org/10.1080/21645515.2026.2649059 | Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65–84 years of age in Belgium: An epidemiological modeling study |
| Evaluation of the cost and length of hospital stays related to the management of an intestinal Clostridium difficile infection. | |
| https://doi.org/10.1093/eurpub/cky218.088 | Assessing the impact of PD-1/PD-L1 inhibitors on health and budget in Belgium |
| https://doi.org/10.1097/01.hjh.0000379021.18191.5a | HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION HAVE A HIGH PREVALENCE OF RENAL DISEASE: RESULTS OF THE BELGICA-STROKE STUDY: PP.16.95 |
| https://doi.org/10.1016/j.jval.2014.08.721 | Cost-Effectiveness of Sitagliptin Versus Sulfonylurea As An Add-On Therapy To Metformin In Patients With Type 2 Diabetes In A Belgium Setting |
| https://doi.org/10.51821/84.1.851 | Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium : an observational study |
| https://doi.org/10.1080/0284186x.2022.2063700 | A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non–small cell lung cancer |
| https://doi.org/10.1136/annrheumdis-2014-eular.2258 | THU0155 Predictors of Low Disease Activity and Remission after One Dose of Golimumab in Patients with Rheumatoid Arthritis |
| https://doi.org/10.1016/j.jval.2019.09.390 | PCN194 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND |
| https://doi.org/10.1016/j.jval.2019.09.389 | PCN193 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH PLATINUM CHEMOTHERAPY AND PEMETREXED FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND |
| https://doi.org/10.1016/j.jval.2023.03.100 | CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium |
| https://doi.org/10.5334/ijic.icic23694 | A deep dive into the 8 caring technology principles and their contribution to integrated primary care. |
| https://doi.org/10.1136/annrheumdis-2014-eular.1185 | AB0373 Integrating Treatment Goals of Physicians, Patients, and Payers during Treatment with Golimumab in Patients with Rheumatoid Arthritis |
| https://doi.org/10.1136/annrheumdis-2014-eular.1699 | AB0405 Baseline Predictors of Remission Rates during Golimumab Treatment for Rheumatoid Arthritis in the GO-MORE Study |
| https://doi.org/10.1136/annrheumdis-2016-eular.5831 | FRI0462 Gender Differences in The Disease Expression and Articular Manifestations among Patients with Psoriatic Arthritis. Data from The Bepas Cohort |
| https://doi.org/10.1136/annrheumdis-2016-eular.5850 | AB0737 Clinical Axial Involvement in Patients with Psoriatic Arthritis Is Underestimated: Impact on Burden of The Disease. Data from The Bepas Cohort |
| https://doi.org/10.1183/13993003.congress-2023.pa1208 | A randomized study to evaluate the effects of single-dose MK-5475 co-administered with sildenafil on systemic hemodynamics |
| https://doi.org/10.1097/01.hjh.0000378601.43461.0e | GENDER DIFFERENCES IN THE EVOLUTION OF BLOOD PRESSURE IN HYPERTENSIVE PATIENTS IN THE PROSPECTIVE BELGICA-STROKE STUDY: RESULTS OF ONE YEAR FOLLOW-UP: PP.7.277 |
| https://doi.org/10.1136/annrheumdis-2015-eular.3061 | SAT0160 Prediction of Remission and Low Disease Activity in Dmard-Refractory Patients with RA Treated with Golimumab |
| https://doi.org/10.1136/annrheumdis-2015-eular.5560 | AB0814 The BEPAS Cohort: A Prospective Cohort of Psoriatic Arthritis in Belgium: Study Design and Baseline Characteristics of the 461 Recruited Patients |
| https://doi.org/10.1136/annrheumdis-2016-eular.3621 | FRI0461 Higher Burden of Disease in Female Psa Patients Compared To Male Patients. Data from The Bepas Cohort |
| https://doi.org/10.1136/annrheumdis-2016-eular.5773 | AB0736 The Bepas Cohort: A Real-Life Multicenter Prospective Cohort of Psoriatic Arthritis in Belgium: Demographics and Baseline Characteristics |
| https://doi.org/10.1093/eurpub/cky212.216 | Projecting the Budget and Health Impact of the PD-1/PD-L1 inhibitors to inform budget planning. |
| https://doi.org/10.1136/annrheumdis-2019-eular.3682 | SAT0363 ENTHESITIS BUT NOT DACTYLITIS CONTRIBUTES TO BURDEN OF DISEASE IN PSA PATIENTS: DATA FROM THE BEPAS REAL LIFE COHORT |
| https://doi.org/10.1016/j.jval.2019.09.1258 | PIN13 FIRST EMA-EUNETHTA PARALLEL CONSULTATION FOR VACCINES |
| https://doi.org/10.1136/annrheumdis-2020-eular.2392 | OP0055 MINIMAL RADIOGRAPHIC DAMAGE OF SACROILIAC JOINTS DETECTED IN PSORIATIC ARTHRITIS PATIENTS |
| https://doi.org/10.1016/j.jtho.2020.10.067 | MO01.19 An Indirect Comparison of Pembrolizumab Monotherapy Versus Ipilimumab+Nivolumab for First-Line Metastatic NSCLC with PD-L1 TPS≥1% |
| https://doi.org/10.1016/j.jtho.2020.10.068 | MO01.20 Pembrolizumab+Chemo versus Atezolizumab+Chemo+/-Bevacizumab for First-Line Nonsquamous NSCLC: A Matching-Adjusted Indirect Comparison |
| https://doi.org/10.1016/j.jtho.2020.10.066 | MO01.18 An indirect Comparison of Pembrolizumab+Chemo vs Ipilimumab+Nivolumab as First-Line Therapies in Patients with PD-L1 TPS≥1% Metastatic NSCLC |
| https://doi.org/10.1016/s1556-0864(21)02011-6 | 169P BEPACT lung: A prospective, multicenter, non-interventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer (NSCLC) |
| https://doi.org/10.1093/eurpub/cky213.216 | Projecting the Budget and Health Impact of the PD-1/PD-L1 inhibitors to inform budget planning. |
| https://doi.org/10.21203/rs.3.rs-39035/v3 | Pattern-mixture model in network meta-analysis of binary missing outcome data: one-stage or two-stage approach? |
| https://doi.org/10.21203/rs.3.rs-39035/v2 | Pattern-mixture model in network meta-analysis of binary missing outcome data: one-stage or two-stage approach? |
| https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1183 | Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) |
| https://doi.org/10.21203/rs.3.rs-4181221/v1 | A Global Industry Survey on Post-Approval Change Management and Use of Reliance |
| https://doi.org/10.1016/j.jval.2024.03.502 | EE203 Number Needed to Treat and Cost of Preventing an Event Analysis for Pembrolizumab in Non-Squamous Metastatic Non-Small Cell Lung Cancer in Colombia |
| https://doi.org/10.1007/s43441-024-00733-3 | Correction: A Global Industry Survey on Post-Approval Change Management and Use of Reliance |
| https://doi.org/10.1002/cpdd.70035 | Phase 1 Study Evaluating the Effects of Single‐Dose Frespaciguat, an Inhaled Soluble Guanylate Cyclase Stimulator, Co‐administered with Multiple‐Dose Sildenafil on Systemic Hemodynamics |
| https://doi.org/10.1080/20523211.2026.2643774 | Quantifying public and private investment in biopharmaceutical R&D: a study of seven middle- and high-income countries |
| https://doi.org/10.1016/j.jvacx.2026.100835 | Paediatric pneumococcal conjugate vaccination reshaped the serotype landscape of adult non-invasive pneumococcal disease in Belgium (2002–2014 and 2020–2023) |
| https://doi.org/10.1016/j.esmoop.2026.108118 | 92P Network meta-analysis of 1L treatments for advanced or recurrent endometrial cancer |
| https://doi.org/10.1007/s00345-026-06399-w | Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation |
| https://doi.org/10.3390/jmahp14030050 | From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient Access |
| https://doi.org/10.2139/ssrn.7386806 | 10M-Belgium: 10 Million Patient Years – Belgian Evaluation of Lipid therapy Growth, Intensification, Use and Management |